Compare Allegion PLC (ALLE) vs Amphastar Pharmaceuticals Inc (AMPH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allegion PLC vs Amphastar Pharmaceuticals Inc — how do they compare? Allegion PLC trades at $168.66 (market cap $14.32B), while Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M). The key difference: Allegion PLC is far larger — about 16.5× Amphastar Pharmaceuticals Inc's market cap, and Allegion PLC pays a 1.26% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ALLE | AMPH | |
|---|---|---|
Market Cap | $14.32B | $868.62M |
Sector | Industrials | Health |
52-Week High | $179.77 | $30.81 |
52-Week Low | $125.65 | $16.87 |
Enterprise Value | $16.03B | $1.27B |
Dividend Yield | 1.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Allegion PLC
Allegion is a global security products company with a portfolio of leading brands, such as Schlage, von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2021, Allegion generated 68% of sales in the United States. The company mainly competes with Swedish-based Assa Abloy AB and Switzerland-based Dormakaba.
Read more on ALLE →About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →
